Impaired Glutamate Clearance as a Consequence of Energy Failure Caused by MPP+ in Astrocytic Cultures
- 1 August 1999
- journal article
- Published by Elsevier BV in Toxicology and Applied Pharmacology
- Vol. 158 (3), 296-302
- https://doi.org/10.1006/taap.1999.8717
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine (MPTP) Decreases Glutamate Uptake in Cultured AstrocytesJournal of Neurochemistry, 1997
- The Neuronal Nitric Oxide Synthase Inhibitor 7-Nitroindazole Also Inhibits the Monoamine Oxidase-B-Catalyzed Oxidation of 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineChemical Research in Toxicology, 1997
- The Rapid L- and D-Aspartate Uptake in Cultured AstrocytesNeurochemical Research, 1997
- NMDA antagonists partially protect against MPTP induced neurotoxicity in miceNeuroReport, 1993
- Production and disposition of 1-methyl-4-phenylpyridinium in primary cultures of mouse astrocytesGlia, 1992
- Chapter 36: Astrocytes and Parkinson's diseaseProgress in brain research, 1992
- Glutamate neurotoxicity and diseases of the nervous systemNeuron, 1988
- Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity.Proceedings of the National Academy of Sciences, 1985
- Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidaseBiochemical and Biophysical Research Communications, 1984
- A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.Proceedings of the National Academy of Sciences of the United States of America, 1983